The ROE as of December 2025 (TTM) for Double Medical Technology Inc. (002901.SZ) is 16.99%

According to Double Medical Technology Inc.’s latest financial reports and current stock price. The company's current ROE is 16.99%. This represents a change of 301.51% compared to the average of 4.23% of the last 4 quarters.

Double Medical Technology Inc. (002901.SZ) Historical ROE (quarterly & annually)

How has 002901.SZ ROE performed in the past?

The mean historical ROE of Double Medical Technology Inc. over the last ten years is 23.03%. The current 16.99% ROE has changed -26.23% with respect to the historical average. Over the past ten years (40 quarters), 002901.SZ's ROE was at its highest in in the June 2017 quarter at 11.80%. The ROE was at its lowest in in the December 2022 quarter at -4.00%.

Double Medical Technology Inc. (002901.SZ) ROE by Quarter and Year

Discovering the peaks and valleys of Double Medical Technology Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Double Medical Technology Inc. (002901.SZ) Average ROE

How has 002901.SZ ROE performed in the past?

The current ROE of Double Medical Technology Inc. (002901.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Double Medical Technology Inc. (002901.SZ) ROE vs. Peers

How is 002901.SZ’s ROE compared to its peers?

Double Medical Technology Inc.’s ROE is less than iRay Technology Company Limited (10.72%), less than Topchoice Medical Corporation (12.35%), less than Liaoning Cheng Da Co., Ltd. (2.92%), less than Autobio Diagnostics Co., Ltd. (12.66%), less than Jafron Biomedical Co.,Ltd. (14.36%), less than Shenyang Xingqi Pharmaceutical Co.,Ltd (37.18%), less than Meinian Onehealth Healthcare Holdings Co., Ltd. (3.98%), less than DaShenLin Pharmaceutical Group Co., Ltd. (15.79%), greater than BGI Genomics Co., Ltd. (-8.71%), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (14.47%),

Build a custom stock screener for Double Medical Technology Inc. (002901.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Double Medical Technology Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Double Medical Technology Inc. (002901.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Double Medical Technology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.